By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Urigen Pharmaceuticals, Inc. 

875 Mahler Road
Suite 235
Burlingame  California  94010  U.S.A.
Phone: 650-259-0239 Fax: 650-259-0901


SEARCH JOBS


Industry
Pharmaceutical






Company News
Urigen Pharmaceuticals, Inc. Announces Closing Of Restructuring, And Post-Close Addition Of New Board Member, And Restructuring Of Bridge Note 7/7/2014 12:26:16 PM
Urigen Pharmaceuticals, Inc. Announces Results Of Shareholder Meeting Vote On Proposed Restructuring 5/30/2014 9:33:03 AM
Decision in Administrative Proceeding Regarding Urigen Pharmaceuticals, Inc.'s Stock 10/2/2012 9:22:47 AM
Urigen Pharmaceuticals, Inc. Financing Update 10/14/2011 2:15:43 PM
Urigen Pharmaceuticals, Inc. Development and Management Update 7/6/2011 9:16:48 AM
Urigen Pharmaceuticals, Inc. Operational Progress Report 3/28/2011 9:17:05 AM
FDA Grants Urigen Pharmaceuticals, Inc.'s URG101 Meeting 8/18/2010 8:22:07 AM
Urigen Pharmaceuticals, Inc. Announces FDA Follow Up 8/11/2010 8:12:25 AM
Urigen Pharmaceuticals, Inc. Files Request for FDA Meeting; Terminates Agreement with Oceanside Pharmaceuticals 4/23/2010 10:28:23 AM
Lowell Parsons, MD To Make Urigen Pharmaceuticals, Inc. Presentation in Atlanta 2/22/2010 11:10:41 AM
12345
//-->